BBIO · BridgeBio Pharma, Inc. · Fails to Deliver
$74.29
+0.02 (+0.03%)
At close · Nov 6
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$14.47B
Shares
194.80M
Volume · Nov 6
3.16M
Avg daily vol (3M)
2.7M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-09-18 | 5,445 | $67.31 | $366,503 |
| 2026-09-14 | 50,173 | $72.44 | $3,634,532 |
| 2026-09-11 | 105 | $72.50 | $7,613 |
| 2026-09-10 | 283 | $76.08 | $21,531 |
| 2026-09-08 | 2 | $74.84 | $150 |
| 2026-09-04 | 123 | $75.41 | $9,275 |
| 2026-09-02 | 4,996 | $76.57 | $382,544 |
| 2026-08-25 | 57 | $81.07 | $4,621 |
| 2026-08-24 | 35 | $81.50 | $2,853 |
Showing 1–9 of 9 settlements
Key facts
CIK
1743881
CUSIP
10806X102
13F (30d)
209 filings
184 filers
Visit website
Investor relations